A detailed history of Israel Englander (Millennium Management LLC) transactions in Natera, Inc. stock. As of the latest transaction made, Millennium Management LLC holds 1,674,165 shares of NTRA stock, worth $213 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares
1,674,165
Previous 2,639,254 36.57%
Holding current value
$213 Million
Previous $241 Million 24.89%
% of portfolio
0.09%
Previous 0.11%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$85.28 - $112.6 $82.3 Million - $109 Million
-965,089 Reduced 36.57%
1,674,165 $181 Million
Q1 2024

May 15, 2024

BUY
$59.21 - $92.9 $66.3 Million - $104 Million
1,118,921 Added 73.6%
2,639,254 $241 Million
Q4 2023

Feb 14, 2024

BUY
$37.55 - $62.64 $30.4 Million - $50.8 Million
810,380 Added 114.15%
1,520,333 $95.2 Million
Q2 2023

Aug 14, 2023

SELL
$47.08 - $55.16 $28.4 Million - $33.3 Million
-603,484 Reduced 45.95%
709,953 $34.5 Million
Q1 2023

May 15, 2023

BUY
$36.57 - $58.29 $11.4 Million - $18.2 Million
311,676 Added 31.11%
1,313,437 $72.9 Million
Q4 2022

Feb 14, 2023

SELL
$34.17 - $47.91 $36.4 Million - $51 Million
-1,064,024 Reduced 51.51%
1,001,761 $40.2 Million
Q3 2022

Nov 14, 2022

SELL
$36.93 - $56.68 $25.6 Million - $39.2 Million
-692,096 Reduced 25.1%
2,065,785 $90.5 Million
Q2 2022

Aug 15, 2022

BUY
$28.13 - $44.54 $10.4 Million - $16.5 Million
371,336 Added 15.56%
2,757,881 $97.7 Million
Q1 2022

May 16, 2022

BUY
$30.32 - $91.33 $32.1 Million - $96.7 Million
1,058,820 Added 79.75%
2,386,545 $97.1 Million
Q4 2021

Feb 14, 2022

BUY
$86.26 - $119.0 $11.5 Million - $15.8 Million
132,840 Added 11.12%
1,327,725 $124 Million
Q3 2021

Nov 15, 2021

SELL
$100.17 - $126.36 $71.9 Million - $90.7 Million
-717,586 Reduced 37.52%
1,194,885 $133 Million
Q2 2021

Aug 16, 2021

BUY
$86.05 - $119.72 $24.3 Million - $33.9 Million
282,769 Added 17.35%
1,912,471 $217 Million
Q1 2021

May 17, 2021

BUY
$91.47 - $124.36 $16.8 Million - $22.9 Million
184,159 Added 12.74%
1,629,702 $165 Million
Q4 2020

Feb 16, 2021

BUY
$66.66 - $111.74 $6.57 Million - $11 Million
98,577 Added 7.32%
1,445,543 $144 Million
Q3 2020

Nov 16, 2020

BUY
$45.89 - $72.67 $20.2 Million - $32 Million
439,717 Added 48.47%
1,346,966 $97.3 Million
Q2 2020

Aug 14, 2020

SELL
$26.36 - $49.86 $23.3 Million - $44.1 Million
-885,167 Reduced 49.38%
907,249 $45.2 Million
Q1 2020

May 14, 2020

BUY
$17.27 - $40.17 $1.3 Million - $3.03 Million
75,359 Added 4.39%
1,792,416 $53.5 Million
Q4 2019

Feb 14, 2020

SELL
$32.1 - $40.4 $15.2 Million - $19.2 Million
-474,676 Reduced 21.66%
1,717,057 $57.8 Million
Q3 2019

Nov 14, 2019

BUY
$25.38 - $34.89 $2.22 Million - $3.06 Million
87,563 Added 4.16%
2,191,733 $71.9 Million
Q2 2019

Aug 15, 2019

BUY
$17.75 - $27.58 $35 Million - $54.4 Million
1,972,357 Added 1496.33%
2,104,170 $58 Million
Q2 2019

Aug 14, 2019

SELL
$17.75 - $27.58 $51.2 Million - $79.6 Million
-2,886,308 Reduced 95.63%
131,813 $113,000
Q1 2019

May 14, 2019

BUY
$11.34 - $20.62 $15 Million - $27.3 Million
1,322,904 Added 78.04%
3,018,121 $62.2 Million
Q4 2018

Feb 14, 2019

SELL
$12.32 - $24.38 $3.58 Million - $7.09 Million
-290,739 Reduced 14.64%
1,695,217 $23.7 Million
Q3 2018

Nov 14, 2018

BUY
$18.82 - $28.96 $23.4 Million - $35.9 Million
1,241,358 Added 166.72%
1,985,956 $47.5 Million
Q2 2018

Aug 14, 2018

BUY
$8.79 - $19.98 $3.77 Million - $8.56 Million
428,376 Added 135.47%
744,598 $14 Million
Q1 2018

May 15, 2018

BUY
$9.0 - $11.95 $1.95 Million - $2.59 Million
216,987 Added 218.66%
316,222 $2.93 Million
Q4 2017

Feb 14, 2018

SELL
$8.99 - $14.31 $314,632 - $500,821
-34,998 Reduced 26.07%
99,235 $892,000
Q3 2017

Nov 14, 2017

BUY
$8.02 - $13.33 $1.08 Million - $1.79 Million
134,233
134,233 $1.73 Million

Others Institutions Holding NTRA

About Natera, Inc.


  • Ticker NTRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 96,957,400
  • Market Cap $12.3B
  • Description
  • Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...
More about NTRA
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.